Viewing Study NCT03017833


Ignite Creation Date: 2025-12-25 @ 2:53 AM
Ignite Modification Date: 2026-02-27 @ 11:19 AM
Study NCT ID: NCT03017833
Status: COMPLETED
Last Update Posted: 2023-10-04
First Post: 2017-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sapanisertib and Metformin in Treating Patients With Advanced or Metastatic Relapsed or Refractory Cancers
Sponsor: M.D. Anderson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Malignant Solid Neoplasm View
None Metastatic Malignant Solid Neoplasm View
None Recurrent Malignant Solid Neoplasm View
None Refractory Neoplasm View
Keywords: